Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 387.35Cr 448.03Cr 57Cr 50Cr 46Cr 42Cr 80Cr 5.5TCr 82Cr 550.81Cr 216.65Cr 2.7TCr 214.61Cr 209.9Cr 9.28TCr P/E 2026 *
8.52x
P/E 2027 * 7.56x
Enterprise Value 387.35Cr 448.03Cr 57Cr 50Cr 46Cr 42Cr 80Cr 5.5TCr 82Cr 550.81Cr 216.65Cr 2.7TCr 214.61Cr 209.9Cr 9.28TCr EV / Sales 2026 *
0.55x
EV / Sales 2027 * 0.51x
Free-Float
-
Yield 2026 *
5.29%
Yield 2027 * 5.95%
09/07 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
29/06 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
29/06 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
12/06 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
26/05 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
27/04 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
30/03 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
27/03 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
27/03 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
27/03 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
06/02 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
13/01 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
30/12 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
1 day-2.78%
1 week+6.71%
Current month+9.38%
1 month+3.24%
3 months-11.84%
6 months-20.99%
Current year-20.63%
1 week 3.29
Extreme 3.29
3.64
1 month 3.07
Extreme 3.07
3.64
Current year 3.07
Extreme 3.07
4.56
1 year 3.07
Extreme 3.07
5.52
3 years 3.07
Extreme 3.07
7.41
5 years 3.07
Extreme 3.07
9.28
10 years 3.07
Extreme 3.07
16
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 37 09/07/2026
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%+6.71%-32.69%-48.30% 59Cr
-1.32%+6.33%-8.03%-5.29% 1.37TCr
-3.30%+12.63%-26.94%-50.04% 545.24Cr
-2.47%+7.12%+1.38%-2.05% 484.26Cr
-5.06%+8.62%+9.27%-34.00% 428.66Cr
-2.65%-5.70%+5.95%-5.37% 384.52Cr
0.00%+8.92%-5.20%-4.44% 357.16Cr
-3.45%+9.54%-3.88%+11.29% 351.33Cr
-3.77%-0.32%-12.63%-22.78% 251.74Cr
-2.82%+2.80%-1.62%+50.74% 191.63Cr
Average -2.76%+3.29%-7.44%-11.02% 442.59Cr
Weighted average by Cap. -2.45%+3.15%-6.19%-10.99%

Financials

2026 *2027 *
Net sales 698.2Cr 807.58Cr 103.01Cr 90Cr 83Cr 77Cr 144.31Cr 9.92TCr 147.52Cr 992.84Cr 390.51Cr 4.86TCr 386.84Cr 378.35Cr 17TCr 756.3Cr 874.78Cr 111.58Cr 98Cr 90Cr 83Cr 156.32Cr 11TCr 159.79Cr 1.08TCr 423Cr 5.26TCr 419.03Cr 409.84Cr 18TCr
Net income 45Cr 53Cr 6.71Cr 5.86Cr 5.41Cr 4.98Cr 9.39Cr 645.73Cr 9.6Cr 65Cr 25Cr 316.25Cr 25Cr 25Cr 1.09TCr 51Cr 59Cr 7.58Cr 6.62Cr 6.11Cr 5.63Cr 11Cr 729.56Cr 11Cr 73Cr 29Cr 357.31Cr 28Cr 28Cr 1.23TCr
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
17/26/17 HK$3.500 -2.78% 10,48,000
16/26/16 HK$3.600 +4.96% 15,30,000
15/26/15 HK$3.430 +2.08% 5,14,000
14/26/14 HK$3.360 +0.30% 7,89,424
13/26/13 HK$3.350 +2.45% 10,00,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.024CNY
Average target price
4.601CNY
Spread / Average Target
+52.13%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock